Cumulative Dose-Response Study of Non-CFC Propellent HFA 134a Salbutamol Sulfate Metered-Dose Inhaler in Patients with Asthma

Chest

Volumn 109, Issue 3, 1996, Pages 702-707

  Kleerup, Eric C ^a   Tashkin, Donald P ^a   Cline, Ann C ^b   Ekholm, Bruce P ^b   Klinger, Nancy M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b 3M COMPANY   (United States)

Author keywords

Aerosol propellants; Albuterol; Asthma; Bronchodilators; Chlorofluorocarbon; Hydrofluoroalkanes; Ozone; Potassium; Salbutamol sulfate; Spirometry

Indexed keywords

SALBUTAMOL; SALBUTAMOL SULFATE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPOKALEMIA; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TACHYCARDIA;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ASTHMA; CHLOROFLUOROCARBONS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYDROCARBONS, FLUORINATED; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; SPIROMETRY; TREATMENT OUTCOME;

EID: 0029915474     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.3.702     Document Type: Article

References (17)

1. Newman SP. Metered dose pressurized aerosols and the ozone layer. Eur Respir J 1990; 3:495-97
2. Molina MJ, Rowland FS. Stratospheric sink for chlorofluoromethanes: chlorine atom-catalyzed destruction of ozone. Nature 1974; 249:810-12
3. Manzer LE. The CFC-ozone issue: progress on the development of alternatives to CFCs. Science 1990; 249:31-5
4. Fisher DA, Hales CH, Wang WC, et al. Model calculations of the relative effects of CFCs and their replacements on global warming. Nature 1990; 344:513-16
5. United Nations Environment Programme. Handbook for the Montreal protocol on substances that deplete the ozone layer. 3rd ed. Nairobi, Kenya: United Nations Enviromnental Programme, Ozone Secretariat, 1993; 8
6. United Nations Environment Programme. Report of the technology and economic assessment panel: Montreal protocol on substances that deplete the ozone layer. Nairobi, Kenya: United Nations Environment Programme, Ozone Secretariat, 1995: 89-99
7. International consensus report on diagnosis and treatment of asthma. Clin Exp Allergy 1992; 22:1-72
8. Guidelines for the management of asthma. Statement by the British Thoracic Society, the British Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal College of General Practitioners, the General Practitioners in Asthma Group, the British Association of Accident and Emergency Medicine, and the British Paediatric Respiratory Group. Thorax 1993; 48:S1-24
9. Morris JF, Koski A, Breese JD. Normal values and the evaluation of forced end-expiratory flow. Am Rev Respir Dis 1975; 111: 755-62
10. Metropolitan Life Foundation. 1983 Metropolitan height and weight tables. Stat Bull Metrop Life Found 1983; 64:2-9
11. American Thoracic Society. Standardization of spirometry - 1987 update. Am Rev Respir Dis 1987; 136:1285-98
12. Ruffin R, Mitchell C, Thompson P, et al. A placebo controlled comparison of the dose-response effects of salbutamol sulfate in chlorofluorocarbon (CFC) vs hydrofluoroalkane (HFA-134a) propellants in asthmatics. Am J Respir Crit Care Med 1995; 151:A58
13. Schuirman DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 1987; 15: 657-80
14. Sherter CB, Conolly JJ, Schilder DP. The significance of volume-adjusting the maximal midexpiratory flow in assessing the response to a bronchodilator drug. Chest 1978; 73:568-71
15. Podrid PJ. Potassium and ventricular arrhythmias. Am J Cardiol 1990; 65:33E-44E
16. Haalboom JRE, Deenstra M, Struyvenberg A. Hypokalaemia induced by inhalation of fenoterol. Lancet 1985; 1:1125-27
17. Crane J, Burgess C, Beasley R. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol and isoprenaline. Thorax 1989; 44:136-40